ResearcherKanazawa UniversityNo recent work listed

Takeharu Sakamoto

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1225-1902; OpenAlex author ID A5022311927. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2020: 1 paper

Papers 1

Mint3 depletion restricts tumor malignancy of pancreatic cancer cells by decreasing SKP2 expression via HIF-1. Last author DOI 10.1038/s41388-020-01423-8 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Shuichi Kaneko MD · 1 shared paper, 2020 · strength 0.11
- Paper Mint3 depletion restricts tumor malignancy of pancreatic cancer cells by decreasing SKP2 expression via HIF-1. DOI 10.1038/s41388-020-01423-8 ↗
Motoharu Seiki · 1 shared paper, 2020 · strength 0.11
- Paper Mint3 depletion restricts tumor malignancy of pancreatic cancer cells by decreasing SKP2 expression via HIF-1. DOI 10.1038/s41388-020-01423-8 ↗
Akane Kanamori · 1 shared paper, 2020 · strength 0.11
- Paper Mint3 depletion restricts tumor malignancy of pancreatic cancer cells by decreasing SKP2 expression via HIF-1. DOI 10.1038/s41388-020-01423-8 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.